The DOI matches its Crossref record; 174 of the 178 references it cites were found in a registry or an index.
Gallic acid: Pharmacological activities and molecular mechanisms involved in inflammation-related diseases
Open accessAbstract
Gallic acid (GA), also known as 3,4,5-trihydroxybenzoic acid, is a natural secondary metabolite and widely isolated from various fruits, plants and nuts. In recent years, GA has received increasing attention for its powerful anti-inflammatory properties. The purpose of this review is to clearly illuminate the pharmacological activities and related molecular mechanisms of GA in inflammatory diseases. After consulting a large number of literatures, we made a comprehensive exposition on the chemical characteristics, plant origins, pharmacokinetics and toxicity of GA, especially its pharmacological activities and mechanisms of action. Although the plant source of GA is very rich, its lower extraction rate limits the application of GA in development. It is worth mentioning that GA can not only be separated from many plants, but also be produced in large quantities through biological and chemical synthesis. According to pharmacokinetic studies, the absorption and elimination of GA after oral administration are fast, while the structural optimization or dosage form adjustment of GA is beneficial to increase its bioavailability. Promisingly, toxicity studies have shown that GA scarcely has obvious toxicity or side effects in a variety of animal experiments and clinical trials. The results show that the anti-inflammatory mechanisms of GA mainly involved MAPK and NF-κB signaling pathways. It thus weakens the inflammatory response by reducing the release of inflammatory cytokines, chemokines, adhesion molecule and cell infiltration. Due to its excellent pharmacological activities, GA is expected to be a potential candidate for the treatment of various inflammation-related diseases. This paper will provide theoretical basis for the clinical application of GA and guide the future research and medicinal development of GA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“GA and its derivatives are a group of polyphenol compounds with potent antioxidative and anti-inflammatory abilities [28].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,776
Singh, D., Agustí, A. G. N., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Criner, G. J., Frith, P. A., Halpin, D. M. G., Han, M. K., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00164-2019 · Cited by 1,994
Research Progress on the Relationship between Atherosclerosis and Inflammation
Zhu, Y., Xian, X., Wang, Z., Bi, Y., Chen, Q., Han, X., Tang, D., & Chen, R. (2018) · Biomolecules · doi:10.3390/biom8030080 · Cited by 900
Vogelmeier, C. F., Criner, G. J., Martínez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00214-2017 · Cited by 899
Fujihara, M., Muroi, M., Tanamoto, K., Suzuki, T., Azuma, H., & Ikeda, H. (2003) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.08.003 · Cited by 580
Toll receptors, CD14, and macrophage activation and deactivation by LPS
Dobrovolskaia, M. A., & Vogel, S. N. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01613-1 · Cited by 562
Regulation of tissue homeostasis by NF-κB signalling: implications for inflammatory diseases
Pasparakis, M. (2009) · Nature reviews. Immunology · doi:10.1038/nri2655 · Cited by 538
Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells
Kim, S.-H., Jun, C.-D., Suk, K., Choi, B.-J., Lim, H., Park, S., Lee, S. H., Shin, H.-Y., Kim, D.-K., & Shin, T.-Y. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj063 · Cited by 495
CNS Drug Design Based on Principles of Blood‐Brain Barrier Transport
Pardridge, W. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70051781.x · Cited by 460
Deep Learning for Drug-Induced Liver Injury
Xu, Y., Dai, Z., Chen, F., Gao, S., Pei, J., & Lai, L. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00238 · Cited by 405
Research works printed but not linked: 6
- Schneide, 2012, Drug molecular design: from entry to master, East China University of Science and Technology Press, China, 174
- Li, 2019, The anti-inflammatory effect of feiyangchangweiyan capsule and its main components on pelvic inflammatory disease in rats via the regulation of the NF-кB and BAX/BCL-2 pathway, Evid. Complement. Alternat. Med., 9585727
- Lee, 2016, Antiviral effects of black raspberry (Rubus coreanus) seed and its gallic acid against influenza virus infection, Viruses, 8, 157, 10.3390/v8060157 · DOI
- Zamudio-Cuevas, 2020, The enzymatic poly (gallic acid) reduces pro-inflammatory cytokines in vitro, a potential application in inflammatory diseases, Inflammation
- Cheng, 2018, Gallic Acid-L-Leucine conjugate protects mice against LPS-Induced inflammation and Sepsis via correcting proinflammatory lipid mediator profiles and oxidative stress, Oxid. Med. Cell. Longev., 10.1155/2018/1081287 · DOI
- Zhou, 2019, Study on the distribution of gallic acid in rat tissues, Chinese pharmacist, 22, 597
Cited by
Sorted by citations
Items 701–729 of 729
Karalatti, S. M., & David, M. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.71551
Beiginejad, H., & Godini, Z. (2026) · Journal of the Iranian Chemical Society · doi:10.1007/s13738-026-03595-8
Arena, K., Ambroselli, D., Vinci, R. L., Mondello, L., Santi, L., Dugo, L., & Dugo, P. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.71600
Phytochemical Profile and Pharmacological Potentials of Solanum dubium (Fresen.)
Osman, W., Mirghani, M., Kosar, A. M., Mohamed, F. I., Khadijah, K., Alqarni, M. H., Foudah, A. I., Ashour, A. A., Aljarba, T. M., & Samra, R. M. (2026) · Natural Resources for Human Health · doi:10.53365/nrfhh/224632
Liu, L., Ju, S., Duan, Y., Zhang, X., Cheng, W., Ding, Y., & Hu, L. (2026) · Journal of Food Science · doi:10.1111/1750-3841.71436
Hegazy, A. M. S., Al-Ghafari, A. B., Doghaither, H. A. A., Elmorsy, E. M., Alshammari, A. N., Ali, M. L. A. E.-A., Salem, H. S., & Abourashed, N. M. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-11055-2
Mandal, S., Sen, D. J., Mahanti, B., Debnath, B., & Deb, N. K. (2026) · Journal of Food Measurement & Characterization · doi:10.1007/s11694-026-04919-1
Watangi, R. U., Harish, D. R., Dodakallanavar, J., Kundu, R., Chand, J., Khatib, N. A., Banerjee, R., Chougule, V., Hegde, H., & Roy, S. (2026) · 3 Biotech · doi:10.1007/s13205-026-05067-5
Guo, F., Zhang, Y., Wu, A., Liu, X., Liu, X., Zhu, Y., Xiao, B., Xie, X., He, Q., Ding, Y., et al. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.03188-25
Self-citationChen, J., 毛淑杰, Liu, N., Lin, D., Zhao, L., Lin, Z., Hu, M., Wei, S., Zeng, X., & Qiu, H. (2026) · Journal of Anatomical Society of India · doi:10.4103/jasi.jasi_60_25
Mohamed, E. A. M., El-Baha, A. M., El‐Settawy, A. A. A., Shetta, N. D., Mohamed, A. A., & Salem, M. Z. M. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.71760
Frumuzachi, O., Nicolescu, A., Martău, G. A., Odocheanu, R., Medeleanu, M. L., Ranga, F., MOCAN, A., Vodnar, D. C., & Crișan, G. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.110099
Chan, H. Y., Wong, K., Lai, Y., Ng, X. H., Ong, T. Y. Y., & Gew, L. T. (2026) · Journal of Biologically Active Products from Nature · doi:10.1080/22311866.2026.2733882
Mazumder, S., Bhattacharya, D., Lahiri, D., Moovendhan, M., Sarkar, T., & Nag, M. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2026.2737065
Kalavathi, R., Vijayakumar, S., Devadharshini, D., Sneha, P., Sakthivel, G., & Praseetha, P. K. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100655
Kou, R.-W., Yusuf, A., Liu, X., Xia, B., Lu, X.-S., & He, Y. (2026) · Natural Product Research · doi:10.1080/14786419.2026.2740608
Plant-derived phytoconstituents with therapeutic potential against leukemia
Pathak, R. S., Vyas, K., Kurup, S., Kikani, A., & Patel, P. K. (2026) · Phytochemistry Reviews · doi:10.1007/s11101-026-10308-9
Antitumor efficacy and safety profile of gallic acid in the murine sarcoma 180 model
Heiden, G. I., COSTA, M. A. D. S., Silva, C. A., de Carvalho, F. M. D. A., Amaral, R. G., Rivero, E. R. C., Modolo, F., GONDAK, R. D. O., & Júnior, R. L. C. D. A. (2026) · Medical Oncology · doi:10.1007/s12032-026-03455-8
Zhao, H., Guan, B., Zhang, K., Peng, F., Yan, Z., Shi, C., Yue, T., Zhang, X., & Zhang, R. (2026) · Food Chemistry · doi:10.1016/j.foodchem.2026.151515
Chu, Z., Li, L., Wei, S., Wen, Z., 吴海波, Li, X., & Lu, Q. (2026) · Mediators of Inflammation · doi:10.1155/mi/6114730
Rethinking anti-inflammatory drug discovery: a cheminformatics perspective
Sreepathi, D., Narasimhamurthy, P., Taj, S., & Kumar, H. S. S. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100693
de Araújo, J. I. F., Frota, L. S., Lopes, F. F. D. S., de Morais, S. M., Moura, L. F. W. G., Guedes, M. I. F., Araújo, M. G., de Lima, F. D. R., de Paiva, C. F., Vieira‐Neto, A. E., et al. (2026) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2026.100910
In-silico evaluation of Parkia biglobosa plant extract for the preservation of raw hides and skins
Bulus, H., Oshibanjo, O., Shekarri, T. N., & Gaiya, J. D. (2026) · NILEST Journal of Science, Technology & Management · doi:10.68772/azm9x803
Saini, D., Khatoon, Z., Bano, U., Mujeeb, M., Ismail, M. V., Akhtar, M., & Najmi, A. K. (2026) · Current Molecular Pharmacology · doi:10.1016/j.cmp.2026.10.001
Gandhi, S. M., Mohite, S. K., Shete, A. S., Dol, H. S., Nagvekar, P. U. V., Desai, A. V., & Disouza, J. (2026) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-026-00687-x
Abd‐Allah, E. R., Hamouda, A. G., & Mahmoud, A. A. N. (2026) · Reproductive Biology · doi:10.1016/j.repbio.2026.101301
Adebisi, A. A., & Farombi, E. O. (2026) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2026.100919
Shinde, P. L., Singh, S., Kumar, V., Chandrika, S. K., Mishra, A., & Mishra, R. (2026) · Antioxidants · doi:10.3390/antiox15111423
Metadata
- Authors
- Bai, J., Zhang, Y., Tang, C., Hou, Y., Ai, X., Chen, X., Zhang, Y., Wang, X., & Meng, X.
- Affiliations
- Chengdu University of Traditional Chinese Medicine (CN)
- Corresponding author
- Wang, Xiaobo
- Meng, Xianli
- Venue
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 133
- Pages
- 110985
- ISSN
- 0753-3322 (ISSN-L)
- OpenAlex
- W3106125810
- Cited by
- 720
- References
- 178
- Citations by year
- 2026: 127 · 2025: 164 · 2024: 159 · 2023: 146 · 2022: 94 · 2021: 30
- FWCI
- 5.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomedicine & Pharmacotherapy (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science and Technology Major Project
- National Natural Science Foundation of China (81773974, 81903922, 81973569)
- National Key Research and Development Program of China (2017YFC1703904)
- National College Students Innovation and Entrepreneurship Training Program (S201910633017)
- Department of Science and Technology of Sichuan Province (19SYXHZ0095, 2018JY0467, 2020YFQ0032)
- State Administration of Traditional Chinese Medicine of the People's Republic of China (201507002)
- Chengdu University of Traditional Chinese Medicine (2020XSGG004, CXTD2018015, CXTD2018020, CZYJC1903)
- Ministry of Science and Technology of the People's Republic of China
- China Postdoctoral Science Foundation (2020M683273)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Phytochemistry and Biological Activities
- Physical Sciences › Chemistry › Organic Chemistry › Tannin, Tannase and Anticancer Activities
- Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
- Keywords
- gallic acid, anti-inflammatory activity, inflammation-related diseases, MAPK signaling, NF-κB signaling, inflammatory cytokines, chemokines, adhesion molecules, pharmacokinetics, bioavailability, toxicity, plant sources
- MeSH terms
- Animals, Anti-Inflammatory Agents, Gallic Acid, Humans, Inflammation, Signal Transduction, Treatment Outcome, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review